China Hospital Priorities — Strategic Themes and Implications for Medtechs Presentations September 18, 2020 Stephen Sunderland Helen Chen
Related Practice Life Sciences & Pharma Healthcare Services MedTech L.E.K., in collaboration with APACMed, conducted a survey with ~400 hospital executives across both public and private hospitals in key APAC markets. 06302022090649
Special Report Life Sciences & Pharma On the Cusp of a Cure: Is Asia Pacific Ready for the Precision Era? (Australia) November 11, 2025
Executive Insights Life Sciences & Pharma China’s Life Sciences Sector in Transition: How Suppliers Can Thrive in the Next Chapter August 29, 2025
Case Study Life Sciences & Pharma Building Resilience in a Commercial-Stage Pharma Company’s Supply Chain April 16, 2025
Case Study Life Sciences & Pharma Global Manufacturing Footprint Rationalization for a Leading Biopharmaceutical Company March 31, 2025 A leading biopharmaceutical company engaged L.E.K. Consulting to optimize its global manufacturing network. The client sought to reduce costs while…
Executive Insights Life Sciences & Pharma The Future of Animal Health: Strategic Lessons from Human Healthcare March 17, 2025
Case Study Private Equity Future Ready: Comprehensive Operational Due Diligence on a Medtech and Life Sciences… February 24, 2025 A private equity firm approached L.E.K. Consulting to conduct operational due diligence on a promising precision medtech and life sciences engineering…